Y-Intercept (HK)’s 10x Genomics TXG Stock Holding History

Y-Intercept (HK)’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-24,543	Closed	-$941K	–	2106
2026 Q2	$941K	Buy	+24,543	New	+$643K	0.02%	1074
2026 Q1	–	Sell	-20,922	Closed	-$341K	–	2070
2025 Q4	$341K	Buy	+20,922	New	+$316K	0.01%	1344
2025 Q3	–	Sell	-81,290	Closed	-$941K	–	2061
2025 Q2	$941K	Buy	+81,290	New	+$741K	0.02%	967
2025 Q1	–	Sell	-17,305	Closed	-$248K	–	1621
2024 Q4	$248K	Sell	17,305 -485	-3%	-$7.65K	0.02%	992
2024 Q3	$402K	Buy	+17,790	New	+$368K	0.02%	883
2024 Q1	–	Sell	-9,884	Closed	-$553K	–	1772
2023 Q4	$553K	Buy	+9,884	New	+$430K	0.05%	548
2023 Q3	–	Sell	-13,356	Closed	-$746K	–	1619
2023 Q2	$746K	Sell	13,356 -11,351	-46%	-$614K	0.08%	397
2023 Q1	$1.38M	Buy	+24,707	New	+$1.15M	0.16%	173
2022 Q1	–	Sell	-1,533	Closed	-$228K	–	960
2021 Q4	$228K	Buy	+1,533	New	+$235K	0.05%	477
2021 Q1	–	Sell	-2,469	Closed	-$352K	–	807
2020 Q4	$352K	Buy	+2,469	New	+$358K	0.15%	258

Other funds holding TXG

Counterpoint Mutual Funds San Diego, California $1.16B AUM 33.78% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Financial Consulate Hunt Valley, Maryland $899M AUM 14.82% 1-Year Est. Return

Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return

Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return

TriaGen Wealth Management Calabasas, California $413M AUM 35.91% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Guardian Partners Toronto, Canada $1.13B AUM 28.37% 1-Year Est. Return

HB Wealth Management Atlanta, Georgia $19.5B AUM 16.96% 1-Year Est. Return

Y-Intercept (HK)'s TXG Position: Q3 2026 in Review

Y-Intercept (HK) sold out of 10x Genomics (TXG) in Q3 2026, closing a stake of 24,543 shares — an estimated $941K sold.

Y-Intercept (HK) first reported a position in TXG in Q4 2020 and held it in 10 quarters. The position peaked at $1.38M in Q1 2023. 77 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

Y-Intercept (HK) reported no remaining 10x Genomics position as of Q3 2026 after selling out during the quarter.
Y-Intercept (HK) sold 24,543 10x Genomics shares in Q3 2026, an estimated $941K.
Y-Intercept (HK) first reported a position in 10x Genomics in Q4 2020 and held it in 10 quarters.
Y-Intercept (HK)'s 10x Genomics position peaked at $1.38M in Q1 2023.
77 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.